Cure For Dengue

[jansky]

[SIZE=2] By Bernardo Rocha Calibo
Director, National Police Commission 7

THERE is hope that the dengue scourge will be obliterated. I was in a
meeting in Manila recently with other Napolcom officials. While
waiting for my flight back to Cebu , I happened to talk with friends.
The conversation eventually turned to dengue. Some of their
statements shocked me. I called up the persons concerned and they
confirmed these revelations.

Computer technician Wenceslao Salesale Jr., 27, was downed by dengue.
His platelet count plunged from 180 to 80. He was rushed by ambulance
from Novaliches to Manila . Inside the ambulance, a relative, acting
upon the advice of a missionary priest, made him drink soup made from
camote tops. The following day, his platelet count became normal.


Dengue attacked the 7-year-old daughter of engineers Mar and Lita
Budlongan of Kaloocan City . Her platelet count read 80. The same
treatment was used. The following day she was back to normal.

The 15-year-old daughter of businessman Nepomuceno Salaga of
Sampaloc, Manila had a dangerous platelet count of 80 due to dengue.
The same treatment was followed. The following day she was back in
school.

I asked a doctor of medicine about herbal cures and he said that
many, if not most, medicines come from plants. He also said that
under the Hippocratic Oath, doctors are bound encourage anything that
can cure a patient.

Research

We need not do research deep in the rainforests of the Amazon or
venture into the ocean depths in search of the elusive cure for
dengue. It is right there in the backyard.

The following information is from Wikipedia:
"In 1992, the Center for Science in the Public Interest compared the
nutritional value of sweet potatoes to other vegetables. Considering
fiber content, complex carbohydrates, protein, vitamins A and C, iron
and calcium, the sweet potato ranked highest in nutritional value.
According to these criteria, sweet potatoes earned 184 points, 100
points over the next on the list, the common potato (NCSPC)."
"...Sweet potato tops are excellent sources of antioxidative compounds,
mainly polyphenolics, which may protect the human body from oxidative
stress that is associated with many diseases including cancer and
cardiovascular diseases. Sweet potato greens have the highest content
of total polyphenolics among other commercial vegetables studied.
"Sweet potatoes contain protein, dietary fiber, lipid, and essential
minerals and nutrients such as calcium, phosphorous, magnesium,
sodium, potassium, sulfur, iron, copper, zinc, manganese, aluminum
and boron. Sweet potatoes are also important sources of vitamin A,
thiamin, riboflavin, niacin and ascorbic acid."

Camote

In the case of Salaga, he bought five sheaves (bugkos/ bigkis) of
camote cuttings. Each sheaf consists of about 12 cuttings. Each
cutting measures about one foot. A sheaf costs about P5.
Camote tops are boiled in water to extract the juice. The boiling
lasts for about five minutes. A little salt is used to give flavor to
it. The patient is made to drink slowly and gradually. The body's
immunity system is thus revived, making dengue helpless against the
body's natural defenses. Camote enables the body to heal itself.

Now you know why I earlier said that my friends' revelations shocked
me. They were shocking because people are needlessly dying all around
us from dengue, while their very cure is also all around us.

In the past, many were fond of using the derogatory statement, "Go
home and plant camote.
" Now, camote is big news. It can save lives. What could be bigger
than that?
So, to fortify your family against dengue, "Go home and plant
camote!"
(Engr. Lita Budiongan and Mr. Nepomuceno Salaga personally related to
me their experiences with their respective daughters. I asked their permission to use
their names.)[/SIZE]

[hominid]

Ive heard of this severak times already. My 2 daughters got infected last year. They just spent 3-4 days on the hospital on dextrose and nothing more.

Pls. clarify for a father like me who doesnt know much about cooking.

What are(how does if look like):

- camote tops?
- camote cuttings?

[pup2]

Sana may mag scientific research or clinical study nito. Tutal, suportive therapy lang ang gamutan sa dengue. Paging the resident tsikot docs! Yoohoo! Doc Otep?

[mikaztro]

Camote tops ba ang Talbos ng Kamote? O iba? Eh ano naman yung Kamoteng kahoy? Totoo kaya ito? Sana totoo nga para maraming matulungan na mga nadale ng dengue.

[Syuryuken]

alam ko talbos ng kamote yan.

[XTO]

Talbos ng kamote po (kamoteng baging to be precise) . Anything organic is very good.


ito nama ang kamoteng kahoy okay rin ihalo sa ginataang tilapia or karpa ang talbos nito.

[shadow]

From what I remember sa akin basta diretso na tumaas platelets consecutively but i always extend my stay sa hospital


Sent from my iPhone using Tapatalk

[_Cathy_]

When I had dengue, after a particularly bad night when my platelets were in the low 40k, they gave me a transfusion. The morning after I woke up so hungry, naubos ko yung breakfast na bigay nung ospital and I asked my mother to buy another meal from the eateries outside. After that the doctor came and said on the road to recovery na daw.

Umabot ka pala sa transfusion. I hope I am on the road to recovery na rin. I have food cravings now.

Yes, that is a good indicator.

As dr.d mentioned and as Cathy's doctor advised, watchful waiting and platelet count.

Thank you. My platelets increased again

Jan 30 177
Jan 31 153
Feb 01 177
Feb 02 229

My doctor said pwede na itabi yung mga gamit for admission at hindi na ko maa admit Tomorrow is my last day for CBC monitoring (supposedly today but I scheduled na kasi)

Take with a grain of salt ... not a doctor ... usually blood tests ... normal platelet count ... that is why do not do anything to artificially inflate platelet count ... research online for how long dengue stays in human body ...

Just take lots of rest ... watch TV shows with at least 10 seasons ... it's not like you have to go back to work or have critical things to do ... aside from worrying about your ancestral lands ...

Again ... NOT a doctor ... just speaking from experience ...

It's a good thing I am used to just staying at home and in my room the whole day, but it gets tiring too. I would rather stress about corporate than stress about the estate. I think that weakened my immunity. I am not used to being on the road daily.

From what I remember sa akin basta diretso na tumaas platelets consecutively but i always extend my stay sa hospital


Sent from my iPhone using Tapatalk

[shadow]

Duterte and PAO Acosta legacy. Siniraan ang dengvaxia


Sent from my iPhone using Tapatalk

[Athrunzala]

Duterte and PAO Acosta legacy. Siniraan ang dengvaxia


Sent from my iPhone using Tapatalk

PAO: 160th Dengvaxia ‘victim’ dies

PAO: 16th Dengvaxia ‘victim’ dies - Manila Standard


"The autopsy on the bodies of the 160 school children showed a pattern of the fatal side effects of the anti-dengue vaccine, including viscerotropism, neurotropism, severe dengue and anaphylactic reaction, he added.

“Sanofi Pasteur Inc. concealed to the Philippines the four risks of its vaccine as early as Dec. 22, 2015,” Erfe said.

In February 2018, Dr. Anthony Leachon, a physician, and former government adviser, said Sanofi Pasteur was well-aware of the risks of its Dengvaxia vaccine in 2015 but did not inform the Philippine government."

[Motortrend]

PAO: 160th Dengvaxia ‘victim’ dies

PAO: 16th Dengvaxia ‘victim’ dies - Manila Standard


"The autopsy on the bodies of the 160 school children showed a pattern of the fatal side effects of the anti-dengue vaccine, including viscerotropism, neurotropism, severe dengue and anaphylactic reaction, he added.

“Sanofi Pasteur Inc. concealed to the Philippines the four risks of its vaccine as early as Dec. 22, 2015,” Erfe said.

In February 2018, Dr. Anthony Leachon, a physician, and former government adviser, said Sanofi Pasteur was well-aware of the risks of its Dengvaxia vaccine in 2015 but did not inform the Philippine government."

From the article:

On Nov. 29, 2017, Sanofi Pasteur issued an official statement posted on its website after a new analysis of six years' worth of clinical data.

“The analysis confirmed that Dengvaxia provides persistent protective benefit against dengue fever in those who had prior infection. For those not previously infected by dengue virus, however, the analysis found that in the longer term, more cases of severe disease could occur following vaccination upon a subsequent dengue infection," it stated.

[Motortrend]

From the WHO website:



"Because of the requirement of pre-vaccination screening, this vaccine is currently not being widely used."

Vaccines and immunization: Dengue

[dr. d]

From the WHO website:



"Because of the requirement of pre-vaccination screening, this vaccine is currently not being widely used."

Vaccines and immunization: Dengue

dengvaxia does not immunize against first infection.
it immunizes against second infection.
it is known that the second infection can be more fatal than the first. hence the vaccine.
but there must be proof, that the potential recipient has had a previous dengue infection.
vaccinating one who has had no previous infection, can be ... problematic.

[Dr.Kamiya]

Duterte and PAO Acosta legacy. Siniraan ang dengvaxia


Sent from my iPhone using Tapatalk

One of the good things Duterte did. Sanofi and PNoy really ****ed up with dengvaxia.

Safety update

Unquantified reduction of risk in the correct cohort, 2x increased risk for dengue-naive recipients:

Overall, vaccinated trial participants had a reduced risk of virologically-confirmed severe dengue and hospitalizations. The subset of trial participants who had not been exposed to dengue virus infection prior to vaccination (i.e. dengue-naïve, seronegative according to the NS1 assay) had a twice higher risk of more severe dengue and hospitalizations compared with unvaccinated participants, regardless of age. In contrast, those trial subjects, at any age, with evidence of a previous dengue infection (as determined by NS1 assay) experienced a reduced risk of severe dengue for the duration of the observation period.

Modest efficacy (15-32%) on the second year, but on year 3 onwards the risk of hospitalization and severe illness becomes higher among vaccinated participants compared to controls:

Based on this new analysis, Sanofi Pasteur estimated the actual risks in the study population. In study subjects aged 2–16 years without prior dengue infection, data suggest modest efficacy (15–32%) of vaccine against symptomatic dengue until the second year of follow-up. Subsequently, starting during year 3, the risk of hospitalized and severe illness becomes higher than among controls. In practical terms, and within the population studied, these data suggest that during a 5-year follow-up, approximately 5 additional hospitalized dengue cases, or 2 additional severe dengue cases, per 1000 vaccinees with no previous dengue infection (i.e. dengue naïve subjects) could occur following vaccination, compared with unvaccinated seronegative children. Importantly, in the clinical trial population, all cases recovered and no deaths were observed. On the other hand, among children who had a prior dengue infection (i.e. seropositive) there was a reduction of 15 cases of hospitalized dengue and 4 cases of severe dengue per 1000 who were vaccinated for the same duration of follow-up.

[Dr.Kamiya]

Report by NPR (generally considered unbiased):
A Vaccine For Dengue, Just Approved By The FDA, Has A Dark History : Goats and Soda : NPR

Here's the problem with Dengvaxia.

Typically, a vaccine works by triggering the immune system to make antibodies against the virus. These antibodies then fight off the virus during an infection.

But dengue is a tricky virus. Dengue antibodies don't always protect a person. In fact, these antibodies can make an infection worse. The dengue virus actually uses the antibodies to help it spread through the body. So a second infection with dengue — when your blood already has antibodies in it — can actually be worse than the first; a person is at a higher risk of severe complications like plasma leakage syndrome.

In its follow-up study, Sanofi found evidence that Dengvaxia acts like the first infection for a person who has not been previously infected. The body produces antibodies against the vaccine, which have a similar potential for harm.

The increased risk seems small. The vaccine raises the risk of hospitalization after a dengue infection from about 1.1% to 1.6%, the follow-up study from Sanofi found. So out of 1 million kids in the Philippines, the vaccine would cause about 1,000 to be hospitalized over five years, Sanofi estimated. (On the other hand, the vaccine would prevent about 12,000 hospitalizations for a new dengue infection in children who have had a prior dengue infection during this same time period.)

But in the world of vaccines, that's not an acceptable risk. A risk needs to be exceedingly small to be tolerated. For example, with the measles vaccine, the risk of encephalitis is about 1 in 1 million, or 1,000 times less than the risk from a measles infection, WHO says.

WHO eventually changed its recommendation. The agency now says the vaccine is safe only for children who have had a prior dengue infection.

By the time Sanofi acknowledged this problem with the vaccine, about 800,000 Philippine children had been vaccinated. The Sanofi study estimated that more than 100,000 of them had never been infected with dengue and should not have received the shot, according to WHO's revised recommendation.

[Athrunzala]

Watch: Dengvaxia: Dengue Fever Vaccine Kills 160 Children In The Philippines

AlbertaTV: Dengvaxia - Dengue Fever Vaccine Kills 160 Children In Philippines
Dengvaxia: Dengue Fever Vaccine Kills 160 Children In The Philippines